Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics.
cell culture
microfluidics
organoid
preclinical models
renal cell carcinoma
xenograft
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
02
2022
accepted:
10
03
2022
entrez:
25
4
2022
pubmed:
26
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
Modeling renal cell carcinoma is critical to investigating tumor biology and therapeutic mechanisms. Multiple systems have been developed to represent critical components of the tumor and its surrounding microenvironment. Prominent
Identifiants
pubmed: 35463327
doi: 10.3389/fonc.2022.871252
pmc: PMC9022005
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
871252Informations de copyright
Copyright © 2022 Shapiro, Virumbrales-Muñoz, Beebe and Abel.
Déclaration de conflit d'intérêts
DB holds equity in Bellbrook Labs LLC, Tasso Inc., Turba LLC, Salus Discovery LLC, Stacks to the Future LLC, Lynx Biosciences Inc., Flambeau Diagnostics, and Onexio Biosystems. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2019 Jun 27;380(26):2581
pubmed: 31242369
Eur Urol Focus. 2017 Dec;3(6):590-598
pubmed: 28753786
Curr Drug Metab. 2018;19(7):577-583
pubmed: 29521220
Oncogene. 2015 May 14;34(20):2631-9
pubmed: 25023703
Front Oncol. 2021 Oct 04;11:744256
pubmed: 34671560
Cancer Res. 2019 Sep 15;79(18):4557-4566
pubmed: 31350295
Cell. 2014 Sep 25;159(1):176-187
pubmed: 25201530
Cancer Cell. 2002 Apr;1(3):237-46
pubmed: 12086860
Carcinogenesis. 2004 Mar;25(3):309-15
pubmed: 14604887
BMC Cancer. 2016 Jul 16;16:485
pubmed: 27422173
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
APL Bioeng. 2021 Jan 21;5(1):010902
pubmed: 33532672
Oncotarget. 2016 Sep 13;7(37):59336-59359
pubmed: 27449081
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Tissue Eng Regen Med. 2020 Dec;17(6):759-771
pubmed: 32399776
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Nucleic Acids Res. 2019 Jan 8;47(D1):D801-D806
pubmed: 30407599
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16538-43
pubmed: 25359211
Nat Rev Nephrol. 2017 Jul;13(7):410-419
pubmed: 28480903
Mol Cancer. 2017 Dec 6;16(1):177
pubmed: 29212548
J Urol. 2021 Aug;206(2):209-218
pubmed: 34115531
Cancer Discov. 2017 Aug;7(8):900-917
pubmed: 28473526
J Natl Compr Canc Netw. 2022 Jan;20(1):71-90
pubmed: 34991070
Lab Chip. 2013 Apr 21;13(8):1612-8
pubmed: 23455642
Sci Transl Med. 2012 Jun 6;4(137):137ra75
pubmed: 22674553
Cell. 2016 Jun 16;165(7):1586-1597
pubmed: 27315476
Cell Death Dis. 2019 Feb 27;10(3):201
pubmed: 30814510
Nat Rev Dis Primers. 2017 Mar 09;3:17009
pubmed: 28276433
Nat Rev Cancer. 2003 Dec;3(12):952-9
pubmed: 14737125
Mol Cancer Res. 2016 Jul;14(7):589-98
pubmed: 27330105
Lab Chip. 2020 Nov 24;20(23):4420-4432
pubmed: 33103699
Mol Cell. 2020 Jun 18;78(6):1019-1033
pubmed: 32559423
Chem Soc Rev. 2020 Sep 1;49(17):6402-6442
pubmed: 32760967
Cancer Discov. 2021 Apr;11(4):933-959
pubmed: 33811125
Cancers (Basel). 2022 Feb 06;14(3):
pubmed: 35159096
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Lancet. 2019 Jun 15;393(10189):2404-2415
pubmed: 31079938
Kidney Cancer. 2018;2(1):23-29
pubmed: 30320241
Sci Rep. 2016 May 31;6:26715
pubmed: 27242131
J Cell Sci. 2003 Jun 15;116(Pt 12):2377-88
pubmed: 12766184
Nat Biomed Eng. 2021 Aug;5(8):847-863
pubmed: 34385693
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
BMJ. 2014 Nov 10;349:g4797
pubmed: 25385470
Nat Rev Urol. 2020 Mar;17(3):137-150
pubmed: 32020040
Nat Med. 2017 Jul;23(7):869-877
pubmed: 28553932
N Engl J Med. 2021 Nov 25;385(22):2036-2046
pubmed: 34818478
World J Oncol. 2020 Jun;11(3):79-87
pubmed: 32494314
Cancers (Basel). 2020 Feb 13;12(2):
pubmed: 32069881
Adv Healthc Mater. 2018 Jan;7(2):
pubmed: 29205920
Neoplasia. 2018 Jun;20(6):610-620
pubmed: 29747161
Cell. 2018 Apr 19;173(3):595-610.e11
pubmed: 29656894
Cancer Treat Rev. 2017 Apr;55:36-45
pubmed: 28314175
Drugs Context. 2018 Jun 05;7:212528
pubmed: 29899754
N Engl J Med. 2018 Apr 05;378(14):1277-1290
pubmed: 29562145
J Pathol. 2011 Oct;225(2):212-21
pubmed: 21710693
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1583-8
pubmed: 11171994
Cell Rep. 2018 Apr 3;23(1):313-326.e5
pubmed: 29617669
Oncogene. 2020 Apr;39(17):3413-3426
pubmed: 32123314
Cell. 2015 Sep 24;163(1):39-53
pubmed: 26406370
Transl Androl Urol. 2021 Mar;10(3):1506-1520
pubmed: 33850785
Eur Urol Focus. 2021 Jan;7(1):152-162
pubmed: 31266731
Nat Genet. 2013 Aug;45(8):860-7
pubmed: 23797736
Curr Opin Biotechnol. 2020 Jun;63:151-156
pubmed: 32070860
Cell. 2018 Apr 19;173(3):581-594.e12
pubmed: 29656895
Nat Rev Cancer. 2006 Oct;6(10):813-23
pubmed: 16990858
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Transl Oncol. 2020 Mar;13(3):100745
pubmed: 32092671
World J Urol. 2018 Dec;36(12):1913-1926
pubmed: 30123932
J Clin Oncol. 2014 Jun 20;32(18):1968-76
pubmed: 24821879
J Urol. 2007 Jan;177(1):346-52
pubmed: 17162089
N Engl J Med. 2019 Mar 21;380(12):1103-1115
pubmed: 30779531
Curr Biol. 2020 Aug 17;30(16):R921-R925
pubmed: 32810447
Biomaterials. 2022 Apr;283:121454
pubmed: 35299086
Exp Mol Med. 2018 Apr 13;50(4):1-10
pubmed: 29651023
Cell. 2018 Jan 11;172(1-2):373-386.e10
pubmed: 29224780
Eur Urol. 2015 Jan;67(1):85-97
pubmed: 24857407
Nat Commun. 2017 Dec 11;8(1):2026
pubmed: 29229903
J Am Soc Nephrol. 2002 Jul;13(7):1837-46
pubmed: 12089379
Nat Protoc. 2014 Aug;9(8):1848-59
pubmed: 25010905
Nat Commun. 2017 Jun 08;8:15770
pubmed: 28593993
Mol Cancer. 2016 Dec 19;15(1):83
pubmed: 27993170
Nature. 2005 Sep 29;437(7059):648-55
pubmed: 16193039
Integr Biol (Camb). 2013 Sep;5(9):1119-29
pubmed: 23644926
Front Oncol. 2020 Sep 22;10:1775
pubmed: 33072556
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
N Engl J Med. 2021 Aug 19;385(8):683-694
pubmed: 34407342
Cells. 2019 Aug 13;8(8):
pubmed: 31412684
Nat Med. 1995 Aug;1(8):822-6
pubmed: 7585187
N Engl J Med. 2017 Jan 26;376(4):354-366
pubmed: 28121507
Cell. 2018 Apr 19;173(3):611-623.e17
pubmed: 29656891
Nat Rev Cancer. 2017 Apr;17(4):254-268
pubmed: 28104906
Nat Mater. 2016 Feb;15(2):227-34
pubmed: 26595121
J Am Soc Nephrol. 2016 Apr;27(4):1015-28
pubmed: 26260164
Cancer Res. 2018 Jun 15;78(12):3135-3146
pubmed: 29724720
J Urol. 2021 Aug;206(2):199-208
pubmed: 34115547
Nat Biomed Eng. 2020 Apr;4(4):394-406
pubmed: 31988457
Nat Med. 2006 Jan;12(1):122-7
pubmed: 16341243
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Nat Med. 2018 Jun;24(6):749-757
pubmed: 29867230
EMBO Mol Med. 2017 Feb;9(2):137-153
pubmed: 28028012
PLoS One. 2012;7(10):e46876
pubmed: 23056504
Nat Commun. 2017 May 10;8:15165
pubmed: 28489074
Cell. 2018 Dec 13;175(7):1972-1988.e16
pubmed: 30550791
Cancer Res. 2006 Mar 1;66(5):2576-83
pubmed: 16510575
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6
pubmed: 23420197
Front Oncol. 2018 Nov 02;8:456
pubmed: 30450335
Nat Genet. 2012 Jun 10;44(7):751-9
pubmed: 22683710
J Biomol Screen. 2016 Oct;21(9):931-41
pubmed: 27233291
J Hematol Oncol. 2017 May 12;10(1):106
pubmed: 28499452
Nat Med. 2015 Nov;21(11):1364-71
pubmed: 26501191
Commun Biol. 2021 Dec 10;4(1):1387
pubmed: 34893703
Urol Oncol. 2017 Aug;35(8):507-515
pubmed: 28551412